On 2 October 2026, a foreign side meeting of the Healthcare and Pharmaceutical Industry Working Group of the Foreign Investors’ Council under the President of the Republic of Kazakhstan (FIC) was held as part of the Working Group’s ongoing activities.

The meeting was chaired by Mr. Adam Aleksejuk, Foreign Co-Chair of the FIC Healthcare and Pharmaceutical Industry Working Group and General Director of SANTO, a member of the Polpharma Group, Central Asia

·       Ms. Zhanna Baidasheva, Director of the Kazakhstan Foreign Investors’ Council Association (KFICA);

·       Ms. Elmira Pistayeva – Senior Government Relations Adviser, KFICA

·       as well as representatives of foreign companies, including EY, Gedeon Richter, Polpharma SANTO, and others.

The meeting focused on the current state of pharmaceutical regulation in Kazakhstan and the implementation of the minutes of the previous Working Group meeting. Participants discussed several key issues, including amendments to investment agreements, the implementation of deregulation measures, medicine pricing, and the need to improve requirements for the control and labelling of medicinal products.

The participants emphasized the importance of maintaining constructive dialogue between government authorities and the foreign business community. They also expressed their commitment to continued cooperation and to promoting responsible pharmaceutical practices in compliance with the applicable healthcare legislation of the Republic of Kazakhstan.